Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CV

CapsoVision (CV) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $6.59 -0.5% on the day +41.9% over 12 months 52-week range $4.46 – $14.42

Share price and insider trades

CV closeInsider buyInsider sale
051015NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $8,592 on 2026-06-08 · Joanne Carol ImperialBought $101,798 on 2026-06-26 · Eliyahou Et Al HarariBought $410,988 on 2026-07-17 · Eliyahou Et Al HarariBought $495,117 on 2026-07-08 · Eliyahou Et Al HarariBought $9,999,993 on 2026-09-15 · Ching Hang ShenBought $9,999,999 on 2026-09-18 · Eliyahou Et Al Harari
Bought, 12 months$21.0M
Sold, 12 months$9K
Insiders buying2
Insiders selling1

CapsoVision insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $21.0M and 1 sold $9K of CV stock on the open market.

CV insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2025: $83 bought (1 trades)$83Q3 2025Q4 2025Q1 2026Q2 2026: $102K bought (1 trades)$102KQ2 2026: $9K sold (1 trades)Q2 2026Q3 2026: $20.9M bought (6 trades)$20.9MQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$20.9M6—0
Q2 2026$102K1$9K1
Q1 2026—0—0
Q4 2025—0—0
Q3 2025$831—0

Valuation, profit and volume

Pick score 44/100
P/E (trailing)n/aSector median 24.7
Market value$351MMedical Devices
Profit margin-214.7%Revenue growth +9.9%
Volume vs. 50-day0.5×Last 5 sessions
Insiders' paper profit+$3.2MOn all tracked purchases +15.2%

Summary

Over the past 12 months, 2 CapsoVision, Inc insiders reported open-market purchases totaling $21.0M, while 1 insider reported sales totaling $9K. Among insiders with enough purchase history to measure, Eliyahou Et Al Harari (10% Owner) has the highest Insider Score at 66. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

CV stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 23SEC Eliyahou Et Al Harari10% Owner Buy 878,7351,396,494 held (+170%) $5.69 $5.0M +15.8% 66
Sep 23SEC Ching Hang Shen10% Owner Buy 878,7347,279,261 held (+14%) $5.69 $5.0M +15.8% —
Sep 23SEC Eliyahou Et Al Harari10% Owner Buy 878,734new position $5.69 $5.0M +15.8% 66
Sep 18SEC Ching Hang Shen10% Owner Buy 878,7342,926,655 held (+43%) $5.69 $5.0M +15.8% —
Jul 21SEC Eliyahou Et Al Harari10% Owner Buy 61,0683,343,119 held (+2%) $6.73 $411K -2.1% 66
Jul 10SEC Eliyahou Et Al Harari10% Owner Buy 81,3003,282,051 held (+3%) $6.09 $495K +8.2% 66
Jul 7SEC Eliyahou Et Al Harari10% Owner Buy 13,8503,200,751 held (+0%) $7.35 $102K -10.3% 66
Jul 1SEC Joanne Carol ImperialDirector Sell 1,2001,687 held (−42%) $7.16 $9K -8.0% —
Feb 6SEC Chen Lung TsaiDirector Buy 20new position $4.17 $83 +58.0% —

Insiders at CapsoVision, Inc

InsiderBoughtSoldLast filingScore
Eliyahou Et Al Harari10% Owner $11.0M — Sep 23, 2026 66
Ching Hang Shen10% Owner $10.0M — Sep 23, 2026 —
Joanne Carol ImperialDirector — $9K Jul 1, 2026 —
Chen Lung TsaiDirector $83 — Feb 6, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

CV stock: common questions

Are CapsoVision, Inc insiders buying CV stock?

In the past 12 months, 2 insiders reported open-market purchases of CV worth $21.0M. The latest was 10% Owner Eliyahou Et Al Harari bought $5.0M of CV at $5.69 — largest purchase by this insider in our records; raises the stake by 170%.

Are CapsoVision, Inc insiders selling CV stock?

1 insiders reported sales worth $9K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CV's 52-week range?

Over the past year CV has traded between $4.46 and $14.42. It last closed at $6.59 on Oct 9, 2026.